|
|
GEO help: Mouse over screen elements for information. |
|
Status |
Public on Mar 01, 2016 |
Title |
CTCF_ChIP_MEF_p20_1 |
Sample type |
SRA |
|
|
Source name |
MEF_p20_1
|
Organism |
Mus musculus |
Characteristics |
cell type: MEF derived p20 iPS
|
Growth protocol |
ESCs and iPSCs were cultured on Mitomycin-C treated MEFs in KO-DMEM (Invitrogen) supplemented with 1% nonessential amino acids (Invitrogen), 0.1 mM β-mercaptoethanol (Invitrogen), 1,000 U/ml LIF (Millipore) and 15% fetal bovine serum (FBS, Invitrogen) (ESC medium). Naïve ESCs were cultured in serum-free N2B27 medium on gelatin-coated dishes. N2B27 medium (500ml) was generated by inclusion of the following: 240ml DMEM/F12 (Invitrogen), 240ml Neurobasal (Invitrogen), 5ml N2 supplement (Invitrogen), 10ml B27 supplement (Invitrogen), 1,000 U/ml LIF (Millipore), 1% nonessential amino acids (Invitrogen), 0.1mM β-mercaptoethanol (Invitrogen), and the small molecules PD0325901 (Stemgent, 1μM) and CHIR (Stemgent, 3μM). CD19 + pre-B cells and Mac1 + macrophages were isolated from bone marrow with monoclonal antibodies to CD19 and Mac-1 (BD Pharmingen) respectively, using MACS sorting (Miltenyi Biotech). B cells were grown in RPMI medium with 10% FBS and 10ng/ml IL-7 (Peprotech); macrophages in DMEM with 10% FBS and 10ng/ml each of CSF1 and IL-3 (Peprotech). MEFs were established from day 13.5 mouseembryos and cultured in DMEM containing 10% FBS. NSC were isolated and cultured aspreviously described (Di Stefano et al., 2009). All media were supplemented with L-glutamineand penicillin/streptomycin (GIBCO). Reprogramming experiments with B cells were performed as previously described (Di Stefano et al., 2014); with MEFs, macrophages and NSCs were conducted by plating 100.000 cells/well on gelatinized plates seeded with irradiated MEFs, using ESC medium supplemented with 2 μg/ml of doxycycline. For the isolation of iPSC lines, doxycycline was washed out after 15 days of reprogramming and colonies with ESC-like morphology were picked at 20 days before further passaging. iPSC lines were expanded for an additional 9 days (3 passages) to obtain P3 iPS cell lines or for 20 passages to obtain P20 iPS cell lines.
|
Extracted molecule |
genomic DNA |
Extraction protocol |
ChIP experiments were performed as described previously (van Oevelen et al., 2008) using an antibody against H3K27ac (ab4729, Abcam) and CTCF (Millipore, 07-729). DNA libraries were prepared using Illumina's reagents and instructions.
|
|
|
Library strategy |
ChIP-Seq |
Library source |
genomic |
Library selection |
ChIP |
Instrument model |
Illumina NextSeq 500 |
|
|
Description |
ChIP
|
Data processing |
Fastq files were aligned to the mouse genome (mm9) using bwa aln. Peak calling was performed using MACS2 (callpeak), with --extsize 180 and -g mm. Genome_build: mm9 Supplementary_files_format_and_content: narrowPeak
|
|
|
Submission date |
Jan 04, 2016 |
Last update date |
May 15, 2019 |
Contact name |
Elzo de Wit |
Phone |
+31 30 2121 800
|
Organization name |
Hubrecht Institute
|
Street address |
Uppsalalaan 8
|
City |
Utrecht |
ZIP/Postal code |
3584 CT |
Country |
Netherlands |
|
|
Platform ID |
GPL19057 |
Series (2) |
GSE76478 |
Cell-of-origin specific 3D genome structure acquired during somatic cell reprogramming [ChIP-Seq] |
GSE76481 |
Cell-of-origin specific 3D genome structure acquired during somatic cell reprogramming |
|
Relations |
BioSample |
SAMN04382642 |
SRA |
SRX1513736 |
Supplementary file |
Size |
Download |
File type/resource |
GSM2026238_CTCF_MEF_p20_1_peaks.narrowPeak.gz |
1.4 Mb |
(ftp)(http) |
NARROWPEAK |
SRA Run Selector |
Raw data are available in SRA |
Processed data provided as supplementary file |
|
|
|
|
|